Taro-bupropion XL (2021-09-13)

TARO-Bupropion XL tablets are being recalled across Canada due to a product safety issue. This recall affects bupropion XL medication distributed in Canada. The recall is classified as Class I, which indicates a serious safety concern.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2021-09-13

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/ed335e27-c0e7-49dd-bff5-db70668d0b19